drugset / Trial / NCT07360002
The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy
Not yet recruiting
102 enrolled
Keda Lu
Affiliated Hospital of Jiaxing University · collabHangzhou Traditional Chinese Medicine Hospital · collabHangzhou Xiaoshan First People's Hospital · collabJiangsu Province Hospital of Traditional Chinese Medicine · collabRed Cross Hospital, Hangzhou, China · collabShanghai 6th People's Hospital · collabShao Yifu Hospital of Zhejiang Medical University · collabThe First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine · collabThe First Affiliated Hospital of Zhejiang Chinese Medical University · collabThe Second Affiliated Hospital of Zhejiang Chinese Medical University · collabYuyao City Traditional Chinese Medicine Hospital · collabZhejiang University · collabZhenhai District Traditional Chinese Medicine Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to learn if Shenqi Yishen Granules works to treat IgA Nephropathy in adults. It will also learn about the safety of Shenqi Yishen Granules. The main questions it aims to answer are: Does Shenqi Yishen Granules lower 24-hour urinary protein quantification of participants? What medical problems do participants have when taking Shenqi Yishen Granules? Researchers will compare Shenqi Yishen Granules to a placebo (a look-alike substance that contains no drug) to see if Shenqi Yishen Granules works to treat IgA Nephropathy.
Timeline
- Start
- 2026-01
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irbesartan | Small molecule | — | — |